Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to spotlight biotech stocks in his "Best Stocks ...

Generate Biomedicines focuses on AI-enabled drug discovery.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

The company is on the verge of becoming a commercial-stage biotech, with two promising therapies in phase 3 trials.

Less than two months after a record-breaking IPO, SpaceX is set to publish its first quarterly results after markets close on Tuesday, as the share price of Elon Musk's rocket ship and AI company has ...

Sichuan Kelun-Biotech Biopharmaceutical stock has delivered a very large 3 year gain, yet current valuation checks and market ...

Legend Biotech stock has seen a steep share price decline over the past few years, yet the latest valuation checks still ...

I'm messing with you, I know you would rather watch your parents kiss than listen to another monologue about tokens and data ...

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

Legend Biotech has frequently been at the center of takeover rumors, and the stock regularly spikes on speculation that it has received formal buyout bids. It stands out as one of the most uniquely ...